Brooklyn Investment Group bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 632 shares of the company’s stock, valued at approximately $70,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Eastern Bank bought a new position in shares of Cardinal Health in the third quarter valued at $25,000. Frazier Financial Advisors LLC grew its position in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares in the last quarter. Cultivar Capital Inc. purchased a new position in Cardinal Health during the 2nd quarter worth approximately $27,000. Hara Capital LLC purchased a new position in shares of Cardinal Health during the 3rd quarter valued at $31,000. Finally, LRI Investments LLC acquired a new position in shares of Cardinal Health in the first quarter worth $32,000. Institutional investors own 87.17% of the company’s stock.
Cardinal Health Trading Up 0.2 %
Shares of CAH stock opened at $122.63 on Friday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $126.14. The firm’s fifty day moving average price is $114.51 and its two-hundred day moving average price is $106.41. The firm has a market capitalization of $29.68 billion, a P/E ratio of 23.86, a PEG ratio of 1.52 and a beta of 0.60.
Cardinal Health Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.65%. Cardinal Health’s dividend payout ratio is 39.30%.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on CAH. Mizuho upped their price target on shares of Cardinal Health from $110.00 to $120.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Morgan Stanley increased their target price on shares of Cardinal Health from $119.00 to $127.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Argus upped their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday, September 11th. Finally, Evercore ISI upped their price target on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a report on Thursday, August 15th. One analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $123.00.
View Our Latest Research Report on Cardinal Health
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Five stocks we like better than Cardinal Health
- P/E Ratio Calculation: How to Assess Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Top Stocks Investing in 5G Technology
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Overbought Stocks Explained: Should You Trade Them?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.